Pharvaris Statistics

Total Valuation

Pharvaris has a market cap or net worth of $1.10 billion. The enterprise value is $698.94 million.

Market Cap	1.10B
Enterprise Value	698.94M

Important Dates

The last earnings date was Wednesday, May 8, 2024, after market close.

Earnings Date	May 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Pharvaris has 53.82 million shares outstanding. The number of shares has increased by 21.30% in one year.

Shares Outstanding	53.82M
Shares Change (YoY)	+21.30%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.53%
Owned by Institutions (%)	85.79%
Float	20.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.81
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-123.96

Financial Efficiency

Return on equity (ROE) is -39.70% and return on invested capital (ROIC) is -28.98%.

Return on Equity (ROE)	-39.70%
Return on Assets (ROA)	-37.40%
Return on Capital (ROIC)	-28.98%
Revenue Per Employee	n/a
Profits Per Employee	-$1.41M
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Pharvaris has paid $1.39 million in taxes.

Income Tax	1.39M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +139.41% in the last 52 weeks. The beta is -3.12, so Pharvaris's price volatility has been lower than the market average.

Beta (1Y)	-3.12
52-Week Price Change	+139.41%
50-Day Moving Average	22.54
200-Day Moving Average	22.34
Relative Strength Index (RSI)	41.57
Average Volume (30 Days)	71,174

Short Selling Information

The latest short interest is 118,678, so 0.22% of the outstanding shares have been sold short.

Short Interest	118,678
Short Previous Month	90,361
Short % of Shares Out	0.22%
Short % of Float	0.59%
Short Ratio (days to cover)	1.48

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-113.31M
Pretax Income	-114.22M
Net Income	-115.50M
EBITDA	-113.03M
EBIT	-113.31M
Earnings Per Share (EPS)	-$2.71

Full Income Statement

Balance Sheet

The company has $400.74 million in cash and $207,214 in debt, giving a net cash position of $400.53 million or $7.44 per share.

Cash & Cash Equivalents	400.74M
Total Debt	207,214
Net Cash	400.53M
Net Cash Per Share	$7.44
Equity / Book Value	390.76M
Book Value Per Share	7.26
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$100.18 million and capital expenditures -$110,596, giving a free cash flow of -$100.29 million.

Operating Cash Flow	-100.18M
Capital Expenditures	-110,596
Free Cash Flow	-100.29M
FCF Per Share	-$2.45

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pharvaris does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.30%
Shareholder Yield	-21.30%
Earnings Yield	-10.51%
FCF Yield	-9.12%

Analyst Forecast

The average price target for Pharvaris is $31.50, which is 54.79% higher than the current price. The consensus rating is "Buy".

Price Target	$31.50
Price Target Difference	54.79%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2